Membrane protein-chimeric liposome-mediated delivery of triptolide for targeted hepatocellular carcinoma therapy
Triptolide (TPL) is a diterpenoid triepoxide with broad antitumor efficacy, while lack of mechanism of action, severe systemic toxicity, and poor water solubility of TPL limited its usage. To unveil the mechanism of action and improve the pharmaceutical properties of TPL, here we explored the molecu...
Main Authors: | Yanwen Zheng, Fanhua Kong, Songyang Liu, Xi Liu, Dongni Pei, Xiongying Miao |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/10717544.2021.1983072 |
Similar Items
-
Synergetic delivery of triptolide and Ce6 with light-activatable liposomes for efficient hepatocellular carcinoma therapy
by: Ling Yu, et al.
Published: (2021-07-01) -
C-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cells
by: Shu-Guang Li, et al.
Published: (2018-03-01) -
Renal-targeted delivery of triptolide by entrapment in pegylated TRX-20-modified liposomes
by: Yuan Z, et al.
Published: (2017-08-01) -
Triptolide-Mediated Apoptotic Cell Death Accelerated by Metformin Co-Treatment in MiaPaca-2 Cells
by: Zeynep Elif Apaydin, et al.
Published: (2019-12-01) -
Downregulation of miR-200a Protects Mouse Leydig Cells Against Triptolide by Triggering Autophagy
by: Miao H, et al.
Published: (2020-11-01)